<DOC>
	<DOC>NCT00944502</DOC>
	<brief_summary>To evaluate the efficacy and tolerability of Vitatonus Dexa compared with dexamethasone in the signs and symptoms of neuralgia of various origins. Clinical study, randomized prospective and random in nature, with a patients diagnosed with neuralgia of diverse origin. Patients will be include in sufficient quantity to achieve the minimum of 104 evaluable patients.</brief_summary>
	<brief_title>To Evaluate the Efficacy and Tolerability of the Use of Vitatonus Dexa Compared to Dexamethasone in Patients With Neuralgia of Various Origins</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>1. Patients who consent to participate in the study by signing the ICF; 2. Patients of any ethnic group of both sexs aged over 18 years; 3. Patients with clinical diagnosis of neuralgia of various origins. 4. Patients who present scores on the Visual Analogue Scale (VAS) greater than or equal to 4 for PAIN. 1. Patients with known hypersensitivity to lidocaine and thiamine or any component of the formula; 2. Pregnant women and nursing mothers; 3. Hypertensive or cardiac patients; 4. Patients with history of ulcers in the stomach or duodenum, diabetes mellitus or severe infections; 5. Patients who use levodopa, salicylates, colchicine, aminoglycosides, chloramphenicol, anticonvusivantes or potassium supplement. 6. Patient with a history of alcohol or use illicit drugs;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Neuralgy</keyword>
	<keyword>Dexamethasone</keyword>
	<keyword>Complex Vitamins</keyword>
	<keyword>Injection</keyword>
	<keyword>Symptoms of neuralgy of various origins</keyword>
</DOC>